Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative perspective is not particularly high on a per capita basis or as a percentage of GDP. China's exceptionally high rate of pharmaceutical expenditure has important implications for the future of a health care system that not only serves a rapidly...
See More
DETAILS
-
2010/06/01
-
Working Paper (Numbered Series)
-
58413
-
1
-
2010/12/14
-
Disclosed
-
Executive summary
-
payments for health services
Citation
A generic drug policy as cornerstone to essential medicines in China (Vol. 1 of 2) : Executive summary (English). China health policy notes ; no. 4 Washington, DC: World Bank. http://documents.worldbank.org/curated/en/825591468221677572